0
Letters |

Diet and Breast Cancer RecurrenceDiet and Breast Cancer Recurrence

JAMA. 2007;298(18):2135-2136. doi:10.1001/jama.298.18.2135-a
Text Size: A A A
Published online

AUTHOR INFORMATION

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

DIET AND BREAST CANCER RECURRENCE

To the Editor: In the Women's Healthy Eating and Living (WHEL) randomized trial, Dr Pierce and colleagues1 evaluated the effect of increased dietary fruits and vegetables on breast cancer recurrence. We agree with the authors that the differences they report in between-group fat intake for participants in this trial may not have been sufficient to adequately test the dietary fat hypothesis that was raised by the interim results of the Women's Intervention Study (WINS).2

In the WHEL study, while there was a significant difference between groups in fat intake, the long-term reduction in fat from baseline entry in the intervention group was minimal. The reported percentage energy from fat was 28.5% at baseline, 27.1% at 48 months, and 28.9% at 72 months; there were no weight differences between groups. In WINS, patients were entered only up to 1 year after diagnosis (mean, 7.4 months) while the patients in the WHEL study were entered up to 4 years after diagnosis (mean, 23.5 months), thus missing the early recurrence peak seen for receptor negative cancers,3 the type for which greatest benefit for dietary intervention was seen with the WINS intervention.2 In addition, the WHEL study had statistically significant differences between the dietary intervention and control groups in both prior bilateral oophorectomy (P = .01) and ever antiestrogen use (P = .03), which required a post hoc analytic plan incorporating a new stratum; this complicates interpretation of the study results.

The hypothesis raised by the interim results of WINS is that in postmenopausal women, a substantial reduction in dietary fat intake associated with moderate weight loss may reduce breast cancer recurrence, most prominently in women with receptor-negative cancers.2 The WHEL study entered both premenopausal and postmenopausal women, led to limited long-term fat intake reduction, did not find a weight difference between groups, and frequently entered patients after the period of early receptor-negative cancer recurrence. Because of these differences, we believe that the WHEL results provide no direct test of the interim WINS findings. As defined by the study protocol, definitive results regarding the potential effect of the WINS dietary intervention on survival are anticipated in mid-2008.

Financial Disclosures: None reported.

References
Pierce JP, Natarajan L, Caan BJ.  et al.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) Randomized Trial.  JAMA. 2007;298(3):289-298
PubMed
Chlebowski RT, Blackburn G, Thomson CA.  et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.  J Natl Cancer Inst. 2006;98(24):1767-1776
PubMed
Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy.  J Clin Oncol. 1996;14(10):2738-2746
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Pierce JP, Natarajan L, Caan BJ.  et al.  Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) Randomized Trial.  JAMA. 2007;298(3):289-298
PubMed
Chlebowski RT, Blackburn G, Thomson CA.  et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.  J Natl Cancer Inst. 2006;98(24):1767-1776
PubMed
Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy.  J Clin Oncol. 1996;14(10):2738-2746
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.